Kidney microstructural features appear predictive of progressive CKD and mortality following radical nephrectomy.
The 2020 update highlights the importance of accurate diagnosis of upper tract urothelial carcinoma, risk stratification, close follow-up of patients receiving kidney-sparing management, and other key aspects of care.
Immunotherapy improved median overall survival by 7.5 months regardless of what other treatments patients received.
There is evidence to support the role of metastasectomy in providing patients with mRCC an improvement in certain clinical outcomes.
Investigators highlight the importance of preoperative renal biopsy to rule out an indolent or benign tumor in patients with stage 4 CKD.
Patients who underwent ureteroscopic management of low-risk UTUC had a 5-year cancer-specific survival rate of 92.6%.
A study showed that mortality risk was reduced by 59% for patients who underwent complete metastasectomy compared with those who did not.
Hemodialysis was found to be a poor prognostic factor for patients with RCC.
Overall and disease-free survival among patients undergoing surgical resection for MIUC is low despite increasing use of neoadjuvant chemotherapy.
The purpose of this trial was to determine if suppression of MDSCs with acalabrutinib could enhance pembrolizumab activity safely in this population.
The social media platform can be useful as an education tool for oncologists to stay up to date on new research in oncology — but physicians still need to be mindful of the information sources.
Clear cell renal cell carcinoma tumors grow at a faster rate than papillary type 1 tumors, according to a new study.
It remains important to interrogate how structural discrimination influences the collection of patient-reported outcomes.
An assay that measures tumor-derived cell-free DNA in plasma discriminated between patients with and without renal cell carcinoma with 99% accuracy.
Multiparametric magnetic resonance imaging is highly accurate in differentiating nonmuscle-invasive from muscle-invasive bladder cancer, according to a new systematic review and meta-analysis.
In a study, modified Glasgow prognostic score predicted nonorgan-confined disease and lymph node invasion at surgery.
The increase is thought to be related to environmental factors.
Black patients were half as likely to receive remdesivir as White patients, according to researchers from the CCC19.
Combining 2 predictors yielded better results than just using 1.
Recent research suggests cancer patients who have undergone genetic testing for inherited or acquired mutations were more likely to have prolonged overall survival than patients who did not,